P1* (US$) | P2* (US$) | P3* (US$) | |
---|---|---|---|
*P1 = “no specific management” programme. P2 = performing caesarean sections for women who present with genital lesions at the time of delivery. P3 = aciclovir therapy for partners to suppress asymptomatic shedding of HSV. Financial cost is the value of the resources consumed or saved by the programme. Opportunity cost is the forgone benefits because the resource is not available for its best alternative use. Economic cost is the sum of the financial and opportunity cost.15 | |||
Implementation costs (US$) | |||
Financial | – | 110 528 | 42 189 275 |
Opportunity | – | 502 999 | 15 957 443 |
Economic | – | 613 528 | 58 146 718 |
Total costs associated with: | |||
Training | – | 101 463 | 1 030 554 |
Screening | – | 0 | 49 540 509 |
Treatment | – | 502 999 | 8 041 487 |
Surveillance | – | 9065 | 8063 |
Cost of the consequences (US$) | |||
Financial | 21 948 876 | 20 167 699 | 4 033 540 |
Opportunity | 21 903 130 | 20 125 665 | 4 025 133 |
Economic | 43 852 006 | 40 293 364 | 8 058 673 |